VRP Rhineland Palatinate Fund
1
5M
1
- Stages of investment
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 3 participants. Despite the VRP Rhineland Palatinate Fund, startups are often financed by Rheinland-Pfalz Fonds, KfW, High-Tech Gru00fcnderfonds. The meaningful sponsors for the fund in investment in the same round are KfW, High-Tech Gru00fcnderfonds.
The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2010. The common things for fund are deals in the range of 5 - 10 millions dollars.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Galantos Pharma Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Investments by industry
- Biotechnology (1)
- Health Care (1)
- Biopharma (1)
- Pharmaceutical (1)
- Investments by region
-
- Germany (1)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Galantos Pharma | 10 May 2010 | Biotechnology, Health Care, Pharmaceutical, Biopharma | Late Stage Venture | 5M | Rhineland-Palatinate, Mainz, Germany |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.